European Journal of Gastroenterology & Hepatology

Papers
(The TQCC of European Journal of Gastroenterology & Hepatology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Paper Alert36
Paper alert34
String used for oesophageal capsule endoscopy: help or hindrance?31
Effectiveness and safety of newly introduced endoscopic submucosal dissection in a Western center: a real-life study31
Quality of care in inflammatory bowel disease from patient’s perspective using QUOTE-IBD: a Greek multicenter prospective study27
Suppressed serological vitamin A in patients with liver cirrhosis is associated with impaired liver function and clinical detoriation24
Mid- to long-term outcomes of initial transjugular intrahepatic portosystemic shunt versus anticoagulation for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome24
Fib-4 index predicts prognosis after achievement of sustained virologic response following direct-acting antiviral treatment in patients with hepatitis C virus infection23
Correlating endoscopic findings with pathology to optimize biopsy strategies in gastritis: insights from a large cohort study21
Association of left ventricular diastolic dysfunction with inflammatory activity, renal dysfunction, and liver-related mortality in patients with cirrhosis and ascites19
Comment on ‘Home-based transcutaneous electrical acupuncture-point stimulation for depressive symptoms in inflammatory bowel disease: a randomized feasibility study’19
Prevalence, risk factors, and clinical outcomes of extraintestinal manifestations in inflammatory bowel disease: a population-based study in china18
Coexistence of metabolic-associated fatty liver disease and autoimmune or toxic liver disease17
Cardiac involvement in Wilson’s disease: a retrospective cohort study16
Endoscopic retrograde cholangiopancreatography discharge tool combined with rapid trypsinogen-2 test to predict same-day discharge: a prospective cohort study16
Stereotactic body radiotherapy versus radiofrequency ablation as initial treatment of small hepatocellular carcinoma15
High sustained virologic response rate after 8 weeks of direct-acting antivirals in cancer patients with chronic hepatitis C virus15
Construction and validation of the predictive model for gallbladder cancer liver metastasis patients: a SEER-based study14
Clinical study of probiotics combined with lactulose for minimal hepatic encephalopathy treatment14
SAFE vs. FIB-4: diagnostic accuracy for clinically significant fibrosis in U.S. adults with cardiometabolic risk factors – a NHANES 2017–2020 analysis14
Clinical effects of chemical drugs, fecal microbiota transplantation, probiotics, dietary fiber, and acupuncture in the treatment of chronic functional constipation: a systematic review and network me14
Prevalence and predictors of arthralgia after initiation of vedolizumab in patients with inflammatory bowel disease: a retrospective cohort study13
Sarcopenia is an independent risk factor for short-term mortality in patients undergoing transjugular intrahepatic portosystemic shunt13
Risk prediction model for early postoperative death in patients with hepatocellular carcinoma: a retrospective study based on random forest algorithm and logistic regression13
Paper Alert13
Can albumin reduce the mortality of patients with cirrhosis and ascites? A meta-analysis of randomized controlled trials13
Savings in social expenditures for work incapacity in patients with inflammatory bowel disease depend on access to innovative therapies in Poland13
Paper Alert13
Advanced chronic renal disease is an independent risk factor for inpatient mortality following transjugular intrahepatic portosystemic shunt procedure12
The primary cause of markedly elevated aminotransferases in hospitalized patients with cirrhosis is ischemic hepatitis12
Metabolic dysfunction-associated steatotic liver disease-related hepatic fibrosis increases risk of insulin resistance, type 2 diabetes, and chronic kidney disease12
Epidemiology of liver transplantation and post-LT complications in Germany: nationwide study (2005–2018)12
Comparative efficacy and safety of endoscopic submucosal dissection versus transanal endoscopic microsurgery for the treatment of rectal polyps: a systematic review and meta-analysis12
Efficacy and safety of naldemedine for opioid-induced constipation in older patients with cancer: a retrospective study12
Metabolic dysfunction-associated steatotic liver disease related cirrhosis and incidence of portal vein thrombosis12
Prognostic scores in post-endoscopic retrograde cholangiopancreatography acute pancreatitis: should we use all, some, or none?11
Paper Alert11
Three is not a crowd: improving the study of chronic constipation11
Unveiling the role of gut dysbiosis in non-alcoholic fatty liver disease11
Biological treatment approach to inflammatory bowel disease is similar in academic and nonacademic centres – prime time for decentralisation of inflammatory bowel disease care?11
The role of rectal endoscopic ultrasonography plus fine needle aspirartion and fine needle biopsy in pelvic masses11
Changes in antiviral treatment rate for hepatitis B virus before hepatocellular carcinoma diagnosis: a nationwide Korean study11
Real-world evidence of quality of life improvement in patients with distal ulcerative colitis treated by mesalazine: the Quartz study11
Geographical region and clinical outcomes of patients with primary biliary cholangitis from Western Europe11
Vibration Controlled Transient Elastography in Screening for Silent Liver Diseases10
Mechanism by which oleracein E alleviates TNBS-induced ulcerative colitis10
Disease burden, diagnosis pathways and treatment patterns in patients with eosinophilic esophagitis: a real-world study10
Screening for colorectal cancer: awareness and adherence among Italian women10
After nonsurgical treatment of penetrating Crohn’s disease: indications for subsequent surgical intervention10
Risk factors for decompensation and death following umbilical hernia repair in patients with end-stage liver disease10
Transjugular intrahepatic portosystemic shunt insertion improves muscle mass but not muscle function or frailty measures10
Gallstones, cholecystectomy and the risk of pancreatic cancer: an updated systematic review and meta-analysis of cohort studies10
Endoscopic small bowel balloon dilations in patients with Crohn’s disease: a Danish nationwide cohort study, 1997–201510
Vedolizumab versus ustekinumab in Crohn’s disease with prior anti-tumor necrosis factor failure: an updated meta-analysis10
Investigation of the efficacy and safety of endoscopic wide band resection in the treatment of colorectal polyps10
A nomogram for preoperative prediction of microvascular invasion in ruptured hepatocellular carcinoma10
Adalimumab versus ustekinumab as first-line biological in moderate-to-severe Crohn’s disease: real-life cohort from a tertiary referral center10
Effect of statin use on prognostic outcomes in hepatocellular carcinoma following liver surgery: a systematic review and meta-analysis9
Severe acute respiratory syndrome coronavirus 2 infection does not worsen the course of inflammatory bowel disease in the long term9
Hepatotoxicity associated with vedolizumab: case report in a patient with ulcerative colitis9
Role of vessels encapsulating tumor clusters patterns in hepatocellular carcinoma: a literature review9
The role of the fecal microbiota in inflammatory bowel disease9
Retreatment with anti-tumor necrosis factor therapy in combination with an immunomodulator for recurrence of Crohn’s disease after ileocecal resection results in prolonged continuation as compared to 9
A systematic review and meta-analysis on the efficacy of fecal microbiome transplantation in patients with severe alcohol-associated hepatitis9
Outcome of pharmacological thromboprophylaxis in hospitalized patients with cirrhosis – a systematic review and meta-analysis9
Alcoholic cardiomyopathy in patients with alcoholic liver cirrhosis: a study across 10 years9
Tissue penetration of anti-tumour necrosis factor therapy in perianal fistulising Crohn’s disease: a proof-of-concept study9
Interaction between trouble sleeping and diabetes on metabolic dysfunction-associated fatty liver disease and liver fibrosis in adults results from the National Health and Nutrition Examination Survey9
Sintilimab as adjuvant therapy for high-risk hepatocellular carcinoma after curative resection: a multicentric retrospective cohort study9
Hematological ratios in patients with acute decompensation and acute-on-chronic liver failure: prognostic factors9
Late onset vedolizumab-induced eosinophilic pneumonia in a patient with ulcerative colitis8
The impact of MELD exception points for hydrothorax on posttransplant mortality: a propensity score-matched analysis8
Post-colonoscopy rectal cancer in Swedish patients with Crohn’s disease 2001–2015: a population-based case review study8
Efficacy and safety of tenapanor in the management of irritable bowel syndrome with constipation: a systematic review and meta-analysis8
Massive spontaneous portosystemic shunt is a solid, easily identifiable prognostic factor in patients with cirrhosis8
Combination of fibrosis-4 score and D-dimer: a practical approach to identify poor outcome in COVID-198
Active smoking is associated with the development of adverse events of biological therapy in patients with inflammatory bowel disease8
Efficacy and safety of double- versus single-balloon retrograde enteroscopy8
Paper Alert8
The value of whole-body dual-energy x-ray absorptiometry in assessing body composition in patients with inflammatory bowel disease: a prospective study8
A novel risk score model of esophageal stricture for patients undergoing endoscopic submucosal dissection8
Endoscopy in pediatric polyposis syndromes: why, when and how8
The correlation between serum 25-hydroxyvitamin D level and ulcerative colitis: a systematic review and meta-analysis8
Relation between non-alcoholic fatty liver disease and carotid artery intimal media thickness as a surrogate for atherosclerosis: a systematic review and meta-analysis8
Interaction between dietary flavonoid intake and trouble sleeping on non-alcoholic fatty liver disease risk: a cross-sectional study8
Targeted liver ultrasound performed by an expert is the pivotal imaging examination for low phospholipid-associated cholelithiasis8
Pathogenic factors of cognitive dysfunction after liver transplantation: an observational study8
Biopsies from ulcer edge yield higher histological activity scores than biopsies from non-ulcerated mucosa in active ulcerative colitis8
Navigating the landscape of metabolic-associated steatotic liver disease treatment: aspirin as a potential game changer8
Growth hormone augmentation in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials7
Global liver cancer burden attributed to high body mass index: trends, projections, and its relationship with socioeconomic development status (1990–2021)7
Intestinal ultrasound accurately predicts future therapy failure in Crohn’s disease patients in a biologics-induced remission7
Associations between 12 insulin resistance surrogates with metabolic dysfunction-associated steatotic liver disease risk and all-cause mortality: data from the NHANES III (1988–1994)7
Paper Alert7
Paper Alert7
Analysis of risk factors for fatty liver disease in children with Wilson’s disease7
Pregnancy outcomes in Greek women with inflammatory bowel disease: a longitudinal national retrospective study7
Short-chain fatty acid levels in stools of patients with inflammatory bowel disease are lower than those in healthy subjects7
Safety of percutaneous gastrostomy tube placement in patients with cirrhosis: a multicenter matched cohort study7
Comparative maintenance performance of all biologic agents and small molecules in ulcerative colitis: a network meta-analysis7
Efficacy of antimicrobial therapy in patients with uncomplicated acute colonic diverticulitis: an updated systematic review and meta-analysis7
The impact of nonalcoholic fatty liver disease on inflammatory bowel disease-related hospitalization outcomes: a systematic review7
The frequency and clinical significance of antibodies to soluble liver antigen/liver pancreas in autoimmune hepatitis: a prospective single-center study7
Gastric cancer risk in the elderly is associated with omeprazole use and inversely associated with aspirin use7
Therapeutic effects of biological treatments on AA amyloidosis associated with inflammatory bowel disease: a case report and literature review7
Beyond diagnosis: exploring coeliac disease incidence alongside clinical and laboratory characteristics of newly diagnosed children in Slovenia7
JAK inhibitors for the treatment of inflammatory bowel disease: results of an international survey of perceptions, attitudes, and clinical practice7
Nomogram predicting survival in patients with lymph node-negative hepatocellular carcinoma based on the SEER database and external validation6
Paper Alert6
Risk and incidence of colorectal stricture progressing to colorectal neoplasia in patients with inflammatory bowel disease: a systematic review and meta-analysis6
Transient elastography can stratify patients with Child Pugh A cirrhosis according to long-term risk of decompensation: a longitudinal cohort study6
Prognostic factors of elderly patients with hepatocellular carcinoma: should we be more courageous in treatment?6
Total biopsy via endoscopic submucosal dissection is useful for the diagnosis of neoplastic lesions in patients with ulcerative colitis6
Impact of high-dose glucocorticoid on endothelial damage after liver resection – a double-blinded randomized substudy6
Current insight into enteropathogens in flare-up ulcerative colitis. An observational study6
Development and validation of risk prediction model for bacterial infections in acute liver failure patients6
Characteristics analysis of hepatitis B core–related antigen in children with hepatitis B e antigen–positive chronic viral hepatitis B infection6
Diverticulosis morphology is associated with risk of diverticulitis6
Infectious mononucleosis is associated with an increased incidence of Crohn’s disease: results from a cohort study of 31 862 outpatients in Germany6
Baseline albumin-bilirubin score: a predictor for HBeAg clearance in patients with chronic hepatitis B after nucleos(t)ide analogue treatment6
Nonalcoholic fatty liver disease and colorectal cancer: a two-sample bidirectional Mendelian randomization analysis6
Indirect comparison of endoscopic balloon dilatation, stent placement, and stricturotomy for lower gastrointestinal strictures in Crohn’s disease: a systematic review and meta-analysis6
Assessment of nomogram model for the prediction of esophageal variceal hemorrhage in hepatitis B-induced hepatic cirrhosis6
Transferrin saturation as a surrogate marker for assessment of labile nontransferrin bound iron in chronic liver disease6
Clinical characteristics and quality of life in patients with inflammatory bowel disease-associated anemia in Southeast China6
What does quantitative HBsAg level mean in chronic hepatitis D infection?6
Paper Alert6
Association of alcohol intake with pre-sarcopenia risk in steatotic liver disease: a dose-dependent relationship6
Can quantitative surface antigen levels and systemic immune-inflammation index be predictive as a new indicator for the initiation of treatment in chronic hepatitis b?6
The Primary Cause of Markedly Elevated Aminotransferases in Hospitalized Patients with Cirrhosis in Ischemic Hepatitis: Erratum6
Elucidating the non-genetic risk factors for celiac disease: an umbrella review of meta-analyses6
Positive hepatitis B core antibody is associated with advanced fibrosis and mortality in nonalcoholic fatty liver disease6
Outcomes and safety of atezolizumab plus bevacizumab in the treatment of hepatocellular carcinoma: treatment prognosis and comparison with tyrosine kinase inhibitors in a French multicenter matched re6
Lipopolysaccharide-binding protein in Crohn’s disease patients: a promising noninvasive biomarker monitoring disease activity6
Comprehensive management of modifiable factors and all-cause mortality in patients with metabolic dysfunction-associated steatotic liver disease6
Development of a set of measurable outcome indicators for Flemish patients with inflammatory bowel disease6
Paper Alert6
Administration of maximum dose of mucolytic solution before upper endoscopy – a double-blind, randomized trial6
Letter to the editor regarding ‘First-line anti-TNF agents, ustekinumab and vedolizumab perform similarly in Crohn’s disease’6
Paper Alert6
Risk factors for unclear margin in cold snare polypectomy for colorectal polyp6
Clinical remission in paired phase two and three studies in inflammatory bowel disease: a systematic review with meta-analysis5
Paper Alert5
Intestinal barrier biomarkers in clinical evaluation of patients with inflammatory bowel disease5
Paper Alert5
A meta-analysis of microbiome therapies for hepatic encephalopathy5
Heterogeneity of cardiometabolic and hepatic fibrosis risks in nonalcoholic fatty liver disease among lean, overweight, and obese populations: a multicenter cross-sectional study5
Retrospective review of organ transplant sources in five studies published in the journal5
Attitudes of physicians managing inflammatory bowel disease toward alterations of liver function tests: an Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) survey5
Video capsule endoscopy versus computed tomography enterography in assessing suspected small bowel bleeding: a systematic review and diagnostic test accuracy meta-analysis5
Real-world clinical effectiveness and safety of vedolizumab and ustekinumab in biologic-naive patients with noncomplicated or complex Crohn’s disease: results from the EVOLVE Expansion study5
Gastric atrophy and gastric cancer: a meta-analytical assessment of risk and the influence of topographical distribution5
Myosteatosis is an independent risk factor for overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunting5
Cumulative thiopurine dosing and keratinocyte skin cancer in inflammatory bowel disease: a case-control study5
Combination of psoas muscle mass index and neutrophil-to-lymphocyte ratio as a noninvasive prognostic marker in hepatocellular carcinoma patients undergoing radiofrequency ablation5
Endoscopic failure for foreign body ingestion and food bolus impaction in the upper gastrointestinal tract: an updated analysis in a European tertiary care hospital5
Autoimmune chronic atrophic gastritis: association between chronic proton pump inhibitors use and more severe atrophy and gastric intestinal metaplasia5
Diagnostic accuracy of magnetically controlled capsule endoscopy for gastric conditions: a systematic review and meta-analysis5
Validation and update of a prediction model for risk of relapse after cessation of anti-TNF treatment in Crohn’s disease5
Is histological healing more clinically valuable than endoscopic healing in Crohn’s disease?5
Eosinophilic esophagitis is the leading cause of dysphagia in an outpatient setting5
Risk factors of complications after thermal ablation for hepatocellular carcinoma: the role of assessment of liver background5
Can infodemiological data be used to assess public awareness and predict outcomes in colon cancer?5
Impact of MAFLD criteria on postoperative recurrence of non-B, non-C HCC5
Preferred language and disease severity predict evaluation for liver transplantation among patients admitted with alcohol-associated hepatitis5
Association between novel inflammatory markers and non-alcoholic fatty liver disease: a cross-sectional study5
Second-line infliximab therapy for ulcerative colitis (SLIT-UC): a retrospective cohort study5
Development and validation of the Adult cirrhosiS Knowledge Questionnaire5
Favorable changes in the survival of patients with cancers of digestive organs – Poland, 2000–20195
Prevalence and predictors of nonceliac wheat sensitivity in refractory irritable bowel syndrome and functional dyspepsia: results from a randomized double-blind placebo-controlled study5
Gastrointestinal sequalae months after severe acute respiratory syndrome corona virus 2 infection: a prospective, observational study5
Granulocyte-colony stimulating factor in decompensated liver cirrhosis: a meta-analysis of four randomized controlled trials5
Clinical course and prognostic risk factors of SARS-CoV-2 vaccine-related hepatitis: differentiating severe acute respiratory syndrome coronavirus 2 vaccine-associated liver injury from autoimmune hep5
Epstein–Barr virus infection increases the risk for inflammatory bowel disease5
1.2108089923859